Cargando…

Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2) Vaccination

Detalles Bibliográficos
Autor principal:	Cheng, Newman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2021
Materias:	Letter To The Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490890/ https://www.ncbi.nlm.nih.gov/pubmed/34595867 http://dx.doi.org/10.3988/jcn.2021.17.4.573

Ejemplares similares

Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
por: Hamada, Yohhei
Publicado: (2021)

Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine
por: Qureshi, Muhammad Imran Ahmad, et al.
Publicado: (2022)

Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)

Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)

Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech
por: Okada, Yusuke, et al.
Publicado: (2021)

Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
por: Li, Chunfeng, et al.
Publicado: (2022)

A racing heart post‐Pfizer/BioNTech BNT162b2
por: Teo, Hooi Khee, et al.
Publicado: (2022)

COVID-19 Vaccine Pfizer BioNTech: Soreness at injection site and cerebral venous sinus thrombosis: case report
Publicado: (2021)

Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
por: Altermanini, Mohammad, et al.
Publicado: (2023)

MRI Negative Myelitis Induced by Pfizer-BioNTech COVID-19 Vaccine
por: Cabral, Gonçalo, et al.
Publicado: (2022)

Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccination
por: Matsubara, Akihiro, et al.
Publicado: (2021)

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine
por: Gilio, Michele, et al.
Publicado: (2022)

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers
por: Palich, R., et al.
Publicado: (2021)

Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients
por: Kaiser, Robert A., et al.
Publicado: (2021)

Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
por: Wu, Xiaotian, et al.
Publicado: (2021)

Acute adrenal insufficiency in a patient with panhypopituitarism after vaccination against COVID-19 (BNT162b2 Pfizer-BioNTech)
por: González López, Javier, et al.
Publicado: (2022)

Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine
por: Akiyama, Hiroaki, et al.
Publicado: (2021)

Vulvar Aphthous Ulcer in an Adolescent After Pfizer-BioNTech (BNT162b2) COVID-19 Vaccination
por: Wojcicki, Anna V., et al.
Publicado: (2022)

Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia
por: Beaton, Brendan, et al.
Publicado: (2021)

Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review
por: Dighriri, Ibrahim M, et al.
Publicado: (2022)

Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation?
por: Cazzato, Gerardo, et al.
Publicado: (2022)

Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine
por: Zappa, Martina, et al.
Publicado: (2021)

First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Havla, Joachim, et al.
Publicado: (2021)

Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
por: Tanaka, Fumika, et al.
Publicado: (2021)

Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine
por: Tay, Carol, et al.
Publicado: (2022)

A case of acute interstitial nephritis following the Pfizer–BioNTech COVID-19 vaccine
por: de la Flor Merino, José Carlos, et al.
Publicado: (2022)

“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19-Vaccine-Pfizer-BioNTech: Pulmonary embolism and deep venous thrombosis: case report
Publicado: (2022)

Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2021)

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2022)

Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community
por: Abukhalil, Abdallah Damin, et al.
Publicado: (2023)

Effectiveness of the BNT162b2 (Pfizer-BioNTech) Vaccine in Children and Adolescents: A Systematic Review and Meta-Analysis
por: Sabu, Jewel Maria, et al.
Publicado: (2022)

COVID-19-Vaccine-Pfizer-BioNTech: Venous thromboembolism: case report
Publicado: (2022)

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
por: Islam, Nazmul, et al.
Publicado: (2022)

Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19
por: Nicolardi, Martina, et al.
Publicado: (2022)

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
por: D’Agati, Vivette D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_is8349iree7kbda76n79nb3tol